The expression of the insulin-like growth factors (IGFs) 
Introduction
The insulin-like growth factors I and II (IGFs), also known as somatomedins, are two single-chain polypeptide hormones that are structurally related to proinsulin and are primarily involved Indirect evidence suggesting the capacity for IGF-IR to promote neoplastic growth has been reported by Kaleko et al. (15) . In these studies, overexpression of IGF-IR in NIH 3T3 cells resulted in ligand-dependent neoplastic transformation as well as the ability to form tumors in nude mice, suggesting that, when amplified, this ubiquitous growth factor receptor functions as an oncogenic protein.
This study was designed to investigate the possibility that the malignant phenotype of rhabdomyosarcoma cells could be altered by stably lowering IGF-IR levels using antisense RNA. The antisense RNA technique leads to a reduction in the expression of a target gene at the protein level through the formation of a specific double-stranded RNA hybrid which interferes with normal mRNA transport and translation (16, 17) . We have constitutively expressed IGF-IR antisense transcripts in a human alveolar rhabdomyosarcoma cell line which normally has a high density of IGF-IR at the cell surface and forms aggressive tumors in immunodeficient mice. The antisense clones were analyzed for integration and expression of transfected sequences, IGF-IR receptor number, and in vitro and in vivo growth characteristics. Clones with reduced IGF-IR expression grew at a slower rate in vitro and were less tumorigenic in immunodeficient mice, when compared with parental or vector control lines.
Methods
Cell culture. The human alveolar rhabdomyosarcoma cell line Rh30 was established from the bone marrow of a patient with metastatic tumor and has been described previously (18) . The cells were grown in DME supplemented with 2 mM glutamine, 10% FCS, and 50 Hg/ml gentamicin. Cells were maintained at 370C with 5% CO2 and subcultured by trypsinization.
Soft agar assays. Cell suspensions were plated (2.5 x 103 cells per 35-mm dish) in semisolid medium containing 0.3% Bacto-Agar (Difco Laboratories, Detroit, MI), DME, 10% heat-inactivated, dialyzed FCS, and 50 ,ug/ml gentamicin. When used to inhibit colony formation, the IGF-IR monoclonal antibody aIR-3 (Oncogene Science Inc., Manhasset, NY) was included at a final concentration of 0.5 jig/ml (19) .
Heat-inactivated serum was used as a precaution to prevent potential complement-mediated cell lysis in the presence of the antibody. The dishes were incubated at 370C in a humidified atmosphere containing 7% C02, and colonies were scored after 21 Fig. 2 , the NcoI-linearized pIGF-IR construct results in the production of two 5'-end labeled S1 probes; one protecting the 586-nt endogenous transcript and the other protecting the 114-nt antisense transcript. The 114-nt antisense transcript was identified in all four clones but was absent in the vector-transfected control line. Barely detectable levels of antisense transcript were detectable in clone AS#4, which also had the lowest level of amplification of the expression plasmid as determined by Southern blot. Clones AS#9, AS#12, and AS#23 all had significantly higher levels of antisense transcripts, with AS#23 expressing a two-to threefold greater level of antisense message compared with the other two.
Immunofluorescence with the IGF-IR monoclonal antibody (aIR-3) was then performed to determine IGF-IR expression in the transfected clones, and the distribution of fluorescence intensity was assessed by flow cytometry (Fig. 3) The effects of IGF-IR antisense expression on the in vitro growth characteristics of the transfected clones were next examined. The growth rates of the antisense clones were compared with that of the vector-transfected control and are shown in Fig.  4 . A marked reduction in growth rates for antisense clones AS#9, AS#12, and AS#23 was observed at all serum concentrations tested compared with control cells and AS#4; these differences were most pronounced for growth in 2% serum. Cell viability remained the same for all groups throughout the course of these experiments (> 95%), indicating that our results did not simply reflect reduced viability of antisense clones. These results could be explained in part by the titration of other nonautocrine growth factors normally present in serum and necessary for optimal growth of mesenchymally derived cells (29) .
The effect of reduced IGF-IR expression on anchorage-independent growth was also investigated (Table I (34) . To establish a direct relationship between IGF-IR expression and tumorigenicity in a human tumor model system, we used antisense-mediated inhibition of IGF-IR expression in alveolar rhabdomyosarcoma, a tumor derived from fetal skeletal muscle. This approach is a powerful tool for modulating the synthesis of specific proteins. It has been used in the past to investigate the role of oncogenes such as c-fos and c-myc in the control of cell proliferation and differentiation ( 17, 21 ) as well as to modulate the production of the extracellular matrix components, tissue inhibitor of metalloproteinase and thrombospondin, in order to study their roles in tumor metastasis (35, 36) . Our present work extends this approach by reducing cellsurface expression of IGF-IR with resultant inhibition of both the in vitro and in vivo growth of the tumor.
Four unique antisense-transfected clones were obtained with reduced expression of IGF-IR. The (6, 15, 37) . These results implicate the IGF-IR, at least in part, for the anchorage-independent growth of Rh3O cells. The IGF-IR antisense transfectants were tested for tumorigenicity in immune-deficient mice to determine whether decreased receptor density in vivo is sufficient to suppress the malignant phenotype of this tumor. In these mice, antisense clone AS#9 had greatly reduced tumorigenicity, and AS#23 failed to produce tumors through the 6-mo duration of the study. By contrast, both the vector control line and AS#4, the antisense clone with the highest receptor density, formed tumors rapidly in all animals that were inoculated. These data suggest there is a critical threshold for IGF-IR density required for the neoplastic growth of Rh3O cells in vivo.
This study demonstrates the importance of the interaction of IGF-IR with its ligand(s) for the autocrine or paracrine growth of human rhabdomyosarcoma. The cognate ligand for IGF-IR, IGF-I, is a ubiquitous requirement for the growth of all cells in vitro, and under certain conditions this ligand-receptor system is the sole requirement for the growth of murine fibroblasts (34) . In these studies as well as those of Kaleko (15), 
